Clinical Utility of Sequential Minimal Residual Disease Measurements in the Context of Risk-based Therapy in Childhood Acute Lymphoblastic Leukemia: a Prospective Study
207 citations
FWCI 22.50
Acute Lymphoblastic Leukemia research
Trend
Citation data as of 2026-04-12 (OpenAlex).
Extracted findings
This paper hasn't been extracted into the knowledge graph yet. We're working through the corpus — 4612585 is in the queue.